Related Experiment Video

Updated: Jul 4, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Primary asthma prevention: is it possible?

Allan Becker1, Moira Chan-Yeung

  • 1Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada. becker@cc.umanitoba.ca

Current Allergy and Asthma Reports
|July 1, 2008
PubMed

Insights

Asthma prevention is not achieved by reducing single allergens. Multifaceted allergen reduction strategies show clinical benefits, suggesting complex environmental interactions in allergic diseases.

Area of Science:

  • Pediatric Allergy and Immunology
  • Environmental Health
  • Epidemiology

Background:

  • Asthma is a prevalent chronic childhood disease with epidemic proportions.
  • Gene-environment interactions are critical, especially during early life's "window of opportunity."
  • Allergic diseases may indicate a broader risk for other inflammatory and autoimmune conditions.

Purpose of the Study:

  • To review biologic and sociologic factors in allergy and asthma development.
  • To evaluate the impact of allergen reduction strategies on asthma prevention.
  • To explore the link between allergic diseases and other chronic inflammatory conditions.

Main Methods:

  • Meta-analysis of studies on allergen reduction and asthma prevention.
  • Review of biologic and sociologic factors influencing asthma and allergy.
  • Synthesis of current understanding of asthma and allergy pathogenesis.

Main Results:

  • Reducing single allergens has no impact on asthma prevention.
  • Multifaceted allergen reduction strategies demonstrate clinical benefits.
  • Increasing asthma and allergy prevalence may signal heightened population risk for other inflammatory diseases.

Conclusions:

  • Allergic diseases represent a dysfunctional interaction with the environment.
  • Understanding asthma and allergy complexity may offer insights into other chronic diseases.
  • Targeted, multifaceted environmental interventions are key for asthma prevention.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: